-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Biogen Inc. quarterly/annual Revenues history and growth rate from 2010 to 2024.
- Biogen Inc. Revenues for the quarter ending December 31, 2024 was $2.45B, a 2.87% increase year-over-year.
- Biogen Inc. Revenues for the twelve months ending December 31, 2024 was $9.68B, a 1.62% decline year-over-year.
- Biogen Inc. annual Revenues for 2024 was $9.68B, a 1.62% decline from 2023.
- Biogen Inc. annual Revenues for 2023 was $9.84B, a 3.32% decline from 2022.
- Biogen Inc. annual Revenues for 2022 was $10.2B, a 7.36% decline from 2021.